Oncology

Cancer care providers should prepare to increase clinical capacity as patients return for services after their care was disrupted by COVID-19.

People born with major birth defects face a 74 percent increased cancer risk compared to those with no birth defects, according to a recent study published in The British Medical Journal. 

Tom Weiner, MD, a former oncologist at St. Peter's Health in Helena, Mont., plans to file a lawsuit against the health system after his dismissal in November, reports the Independent Record. 

For many oncologists, providing high-quality, cost-effective care that improves patient outcomes is no small feat — and reimbursement models that adequately encapsulate the complexities of oncology care are few and far between.

Here are four recent cancer partnerships and affiliations formed since Nov. 12. 

Houston-based Baylor College of Medicine named Ernest Ramsay Camp, MD, professor and chief of surgical oncology in the Michael E. DeBakey Department of Surgery's Division of Surgical Oncology Dec. 3. 

Here are five hospitals, health systems and cancer treatment centers that have expanded their cancer care facilities or shared plans to open new centers since Nov. 18. 

The University of California San Francisco and UC Los Angeles received FDA approval Dec. 1 for a new prostate cancer imaging technique that uses a positron emission tomography-sensitive tracer drug to pinpoint prostate cancer tumors.

The rate of cancer among U.S. adolescents and young adults increased nearly 30 percent from 1973 to 2015, with kidney carcinoma rising at the largest rate, according to a JAMA Network study published Dec. 1

Cancer center leadership should prepare for ongoing and proactive communications to their providers, staff, patients, and the broader communities they serve.